• Cytovance Promotes Jesse McCool to CEO contractpharma
    April 06, 2020
    Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), has appointed Dr. Jesse McCool to chief executive officer.
PharmaSources Customer Service